期刊文献+

卫生经济学评价方法在糖尿病筛查和一级预防中的应用 被引量:4

Application of Economic Analysis to Screening and Primary Prevention of Diabetes
原文传递
导出
摘要 糖尿病及其并发症给患者家庭和社会带来沉重的经济负担,利用卫生经济学的评价方法对糖尿病防治措施进行分析,探求最优的糖尿病防治模式,是目前卫生工作的重要研究课题。本文对卫生经济学评价方法在糖尿病筛查和一级预防中的应用进行综述,为糖尿病防治的卫生决策提供参考和借鉴。 For Patients, families and society, it is a heavy economic burden that the costs due to diabetes and its complications. Using economic analysis to evaluating the interventions in diabetic prevention to exploring the optimal model of diabetic prevention becomes more and more important. In this paper, we reviewed the application of economic analysis to screening and primary prevention of diabetes in order to provide referdnce for health decision-making.
出处 《中国慢性病预防与控制》 CAS 北大核心 2009年第3期329-330,F0003,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 糖尿病 糖尿病筛查 一级预防 卫生经济学评价 QALY Diabetes mellitus Diabetes screening Primary prevention Health economics analysis QALY
  • 引文网络
  • 相关文献

参考文献26

  • 1King H, Aubert RE, Hermen WH. Global Burden of Diabetes, 1995- 2025[J].Diabetes Care, 1998, 21: 1414-1431. 被引量:1
  • 2Cowie CC, Rust KF, Ford ES, et al. Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988-1994 and 2005-2006[J]. Diabetes Care, 2009, 32: 287-294. 被引量:1
  • 3王陇德主编..中国居民营养与健康状况调查报告 之一 2002综合报告[M].北京:人民卫生出版社,2005:200.
  • 4徐凌中,孟庆跃.成本效果分析中的产出测量[J].国外医学(卫生经济分册),1997,14(2):78-80. 被引量:4
  • 5舍曼·富兰德,艾伦·C·古德曼.卫生经济学[M].第3版.王健.孟庆跃译.北京:中国人民大学出版社.2004. 被引量:4
  • 6Harris MI, Klein R, Welborn TA, et al.. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis [J].Diabetes Care, 1992, 15: 815- 819. 被引量:1
  • 7Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: literature review and economic modeling[J]. Health Technology Assessment, 2007, 11: 29-25. 被引量:1
  • 8American Diabetes Association.Screening for type 2 Diabetes [J]. Diabetes Care, 2004, 27:11-14. 被引量:1
  • 9American Diabetes Association.Screening for type 2 Diabetes [J]. Diabetes Care, 2002, 25: 21-24. 被引量:1
  • 10Icks A, Haastert B, Gandjour A, et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes [J]. Diabetes Care, 2004, 27: 2120-2128. 被引量:1

二级参考文献22

  • 1Buchanan TA, Xiang A, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes,2002,51:2796-2803. 被引量:1
  • 2Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in the high-risk patients. The heart outcomes prevention evaluation (HOPE) study investigators. N Engl J Med, 2000,342:154-160. 被引量:1
  • 3Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensinconverting- enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril prevention project(CAPPP) randomized trial. Lancet, 1 被引量:1
  • 4Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish trial in old patients with hypertension-2study.lancet,1999,354:1751-1756. 被引量:1
  • 5Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the west of Scotland coronary prevention study. Circulation,2001,103:357-362. 被引量:1
  • 6Kanaya AM, Herrington D, Vittinghoff E, et al. Glycemic effects of postmenopausal hormone therapy: the heart and estrogen/progestin replacement study: a randomized,double- blind,placebo-controlled trial. Ann Intern Med,2003,138:1-9. 被引量:1
  • 7Osei K, Rhinesmith S, Gaillard T, et al. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucosetolerant, first-degree relatives of Afri 被引量:1
  • 8Charles MA, Eschwege E, Grandmottet P, et al. Treatment with metformin of non-diabetic men with hypertension and hypertriglyceridaemia and central fat distribution. The BIGPRO 1.2 Trial. Diabetes Metab Res Rev, 2000,16:2-7. 被引量:1
  • 9Chiasson JL, Josse RG, Gomis R, et al. Acarbose can prevent the progression of impaired glucose tolerance to type 2 diabetes mellitus: results of a randomised clinical trial. The STOP-NIDDM randomised Trial.Lancet,2002,359:2072-2077. 被引量:1
  • 10Hamman RF. Prevention of type 2 diabetes. In: Williams R, Herman W, Kinmonth AL, et al(eds). The evidence brae for diabetes care.John Wiley & Sons, Ltd, New Jersey, 2002 , 75-177 . 被引量:1

共引文献248

同被引文献40

引证文献4

二级引证文献36

;
使用帮助 返回顶部